Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.03, 7.01, 9.01 · 8-K

FF EAI Robotics Ecosystem Inc.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 29, 2026, AIxCrypto Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to change the Company’s corporate name from “AIxCrypto Holding…

Filed Sep 29, 2026Accepted Sep 29, 2026, 5:30 PM EDTCIK 1460702Accession 0001493152-26-044923
Share

Company context

We are an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. Our business now consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS).

Current securities

Historical securities (1)

Recent company filings

  1. Regulation FD DisclosureOct 26, 2026
  2. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureOct 26, 2026
  3. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureOct 14, 2026
  4. Other EventsSep 29, 2026
  5. EFFECT filingSep 14, 2026

Registered securities in this filing

FF EAI Robotics Ecosystem Inc. · 8-K · Filed 2026-09-29

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.001

Symbol
AIXC
Exchange
NASDAQ
Classification
COMMON
Status
Historical · closed Sep 29, 2026
Filing context

Context: AsOf2026-09-29

Dimensions: Not supplied

Accession 000149315226044923 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.03, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.03Item 5.03 - Amendments to Articles/Bylaws
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 29, 2026, AIxCrypto Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to change the Company’s corporate name from “AIxCrypto Holdings, Inc.” to “FF EAI Robotics Ecosystem Inc.” (the “Name Change”). The Certificate of Amendment will become effective at 12:01 a.m. Eastern Time on September 30, 2026. The Certificate of Amendment amends and restates Article I in its entirety to reflect the new name. Pursuant to a unanimous written consent dated September 23, 2026, the Company’s board of directors approved the Certificate of Amendment in accordance with Section 242 of the Delaware General Corporation Law (the “DGCL”). Pursuant to Section 242(d)(1)(A) of the DGCL, no meeting or vote of the Company’s stockholders was required to adopt the Certificate of Amendment. Also by unanimous written consent dated September 23, 2026, the Board adopted an amendment (the “Bylaws Amendment”) to the Company’s Amended and Restated Bylaws, as of August 10, 2021 (the “Bylaws”), to reflect the Name Change. The Bylaws Amendment replaces each reference in the Bylaws to “Qualigen Therapeutics, Inc.” or “AIxCrypto Holdings, Inc.” with “FF EAI Robotics Ecosystem Inc.” The Bylaws Amendment will become effective automatically concurrently with the effectiveness of the Certificate of Amendment at 12:01 a.m. Eastern Time on September 30, 2026. No other changes were made to the Bylaws. In connection with the Name Change, the trading symbol for the Company’s common stock on The Nasdaq Capital Market will change from “AIXC” to “FFR,” effective at market open on September 30, 2026. The foregoing descriptions of the Certificate of Amendment and the Bylaws Amendment do not purport to be complete and are qualified in their entirety by reference to the full text of the Certificate of Amendment and the Bylaws Amendment, copies of which are filed as Exhibits 3.1 and 3.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 29, 2026, the Company presented an investor presentation (the “Investor Presentation”) relating to, among other things, the Company’s business and strategy, its transition to robotics operations, and the proposed acquisition of the robotics business of Faraday Future Intelligent Electric Inc. (“FFAI”), the Company’s majority stockholder. A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The Investor Presentation includes projections prepared by FFAI management for the robotics business on a standalone basis; the Company has not independently verified or adopted such projections as guidance. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. The furnishing of this information shall not be deemed an admission as to the materiality of any information herein that is required to be disclosed solely by Regulation FD.
Filed exhibits (1)

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.